Steven Galson's Insider Trades & SAST Disclosures

Steven Galson's most recent trade in Biocryst Pharmaceuticals Inc. was a trade of 27,181 Automatic Stock Option Grant done . Disclosure was reported to the exchange on June 12, 2025.

Share

Note

This is a custom search result for pattern Steven Galson.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.

All Superstars

"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches "Balanced Fund" but not "Balanced Growth Fund" Balanced Fund: Use this format without quotation marks to search for all funds related to the term "Balanced Fund" The results may include "Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".

Stock	Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Biocryst Pharmaceuticals Inc.	Steven K. Galson	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Jun 2025	27,181	27,181	-		-	Automatic Stock Option Grant
Biocryst Pharmaceuticals Inc.	Steven K. Galson	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Jun 2025	12,500	24,991 (0%)	0%		0	Common Stock
Biocryst Pharmaceuticals Inc.	Steven Galson	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Jun 2024	49,933	49,933	-		-	Automatic Stock Option Grant
Biocryst Pharmaceuticals Inc.	Steven Galson	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Jun 2024	6,820	36,431 (0%)	0%		0	Common Stock
Biocryst Pharmaceuticals Inc.	Steven Galson	Director	Purchase of securities on an exchange or from another person at price $ 5.49 per share.	13 May 2024	21,940	51,551 (0%)	0%	5.5	120,451	Common Stock
Biocryst Pharmaceuticals Inc.	Steven Galson	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Jun 2023	39,072	39,072	-		-	Automatic Stock Option Grant
Biocryst Pharmaceuticals Inc.	Steven Galson	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Jun 2023	16,745	29,611 (0%)	0%		0	Common Stock
Biocryst Pharmaceuticals Inc.	Steven Galson	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	07 Jun 2022	30,022	30,022	-		-	Automatic Stock Option Grant
Biocryst Pharmaceuticals Inc.	Steven Galson	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	07 Jun 2022	12,866	12,866 (0%)	0%		0	Common Stock
Biocryst Pharmaceuticals Inc.	Steven Galson	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Sep 2021	60,000	60,000	-		-	Non-Qualified Stock Option

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades